These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22324906)

  • 1. Human T-lymphotropic virus type 1 and type 2 seroprevalence, incidence, and residual transfusion risk among blood donors in Brazil during 2007-2009.
    Carneiro-Proietti AB; Sabino EC; Leão S; Salles NA; Loureiro P; Sarr M; Wright D; Busch M; Proietti FA; Murphy EL;
    AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1265-72. PubMed ID: 22324906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human T-cell lymphotropic virus type I and II seroprevalence among volunteer blood donors in Thailand.
    Oota S; Chaiwong K; Pikulsod S; Khuenkaew R; Pheakkhuntod S; Rattajak P; Kramkratok P; Shiu C; Bhatnagar S; Sakuldamrongpanich T
    Pathog Glob Health; 2018 Oct; 112(7):343-348. PubMed ID: 30424716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of human T lymphotropic virus antibodies among healthy blood donors at a tertiary centre in Lagos, Nigeria.
    Durojaiye I; Akinbami A; Dosunmu A; Ajibola S; Adediran A; Uche E; Oshinaike O; Odesanya M; Dada A; Okunoye O
    Pan Afr Med J; 2014; 17():301. PubMed ID: 25328597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of Human T-Cell Lymphotropic Virus-1/2 in Blood Donors in Northern Pakistan: Implications for Blood Donor Screening.
    Niazi SK; Bhatti FA; Salamat N
    J Coll Physicians Surg Pak; 2015 Dec; 25(12):874-7. PubMed ID: 26691361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human T-Lymphotropic Virus Type 1 and 2 Seroprevalence among first-time blood donors in Chile, 2011-2013.
    San Martín H; Balanda M; Vergara N; Valenzuela MA; Cartier L; Ayala S; Ramírez E
    J Med Virol; 2016 Jun; 88(6):1067-75. PubMed ID: 26538335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of human T-cell leukemia virus in blood donors in China.
    Li L; Ou S; Huang C; Zhou X; Ge H; Li J; Zeng J; Zhou A; He L; Xu Q; Wu J; Li L; Wang C; Zang L; Huang L; Niu L; Han H; Zhang G; Wan J; Wang F; Xu T; Zhao B; Qian L; Wu Y; Liu Z
    Transfusion; 2019 Jul; 59(7):2361-2367. PubMed ID: 30985961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of anti-HTLV I/II seroprevalence in healthy blood donors in Izmir region, Turkey].
    Sertöz R; Turhan A; Bozkurt H; Samlıoğlu P; Değirmenci A; Aydınok Y; Erensoy S
    Mikrobiyol Bul; 2010 Oct; 44(4):579-84. PubMed ID: 21063970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of HTLV-I/II in blood donors in Monterrey, Mexico.
    Trejo-Avila LM; Fuentes-Pensamiento R; Scorro Flores-Castañeda M; Diaz-Mendoza ML; Zapata-Benavides P; Tamez-Guerra RS
    Arch Med Res; 1996; 27(1):97-9. PubMed ID: 8867376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of HTLV-1/2 Among Voluntary Blood Donors in Vietnam.
    Pham D; Nguyen D; Nguyen TA; Tran C; Tran L; Devare S; Tran A; Bhatnagar S
    AIDS Res Hum Retroviruses; 2019 Apr; 35(4):376-381. PubMed ID: 30565470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in Brazil.
    Catalan-Soares B; Carneiro-Proietti AB; Proietti FA;
    Cad Saude Publica; 2005; 21(3):926-31. PubMed ID: 15868051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serologial screening of human T cell lymphotropic virus I and II (HTLV I/II) in blood banks by immunoblotting and enzyme-immuno assays: to demand or to defeat?
    Kawashti MI; Hindawi SI; Damanhouri GA; Rowehy NG; Bawazeer MM; Alshawa M
    Egypt J Immunol; 2005; 12(2):137-42. PubMed ID: 17977218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of the window period of human T-cell leukemia virus type 1 and 2 tests by a lookback study of seroconverters among Japanese voluntary blood donors.
    Sagara Y; Nakamura H; Yamamoto M; Ezaki T; Koga T; Shimamura M; Satake M; Irita K
    Transfusion; 2021 Feb; 61(2):484-493. PubMed ID: 33368334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of supplementary serologic testing for human T-lymphotropic virus types I and II in US blood donors. Retrovirus Epidemiology Donor Study.
    Busch MP; Laycock M; Kleinman SH; Wages JW; Calabro M; Kaplan JE; Khabbaz RF; Hollingsworth CG
    Blood; 1994 Feb; 83(4):1143-8. PubMed ID: 8111054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in eastern Saudi Arabia.
    Fawaz NA; Tamim H; Almawi WY
    Am J Infect Control; 2005 Apr; 33(3):189-91. PubMed ID: 15798675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of human T-lymphotropic virus (HTLV) recipient tracing (lookback) and the current HTLV-I and -II confirmatory algorithm, 1999 to 2004.
    Stramer SL; Foster GA; Dodd RY
    Transfusion; 2006 May; 46(5):703-7. PubMed ID: 16686837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
    Mangano AM; Remesar M; del Pozo A; Sen L
    J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence and demographic determinants of human T-lymphotropic virus type 1 and 2 infections among first-time blood donors--United States, 2000-2009.
    Chang YB; Kaidarova Z; Hindes D; Bravo M; Kiely N; Kamel H; Dubay D; Hoose B; Murphy EL
    J Infect Dis; 2014 Feb; 209(4):523-31. PubMed ID: 24068702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia.
    Ul-Hassan Z; Al-Bahrani AT; Panhotra BR
    Saudi Med J; 2004 Oct; 25(10):1419-22. PubMed ID: 15494814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HTLV-I/II seroprevalence in 55 Brazilian patients with idiopathic uveitis.
    Pinheiro SR; Carneiro-Proietti AB; Lima-Martins MV; Proietti FA; Pereira AA; Oréfice F
    Rev Soc Bras Med Trop; 1996; 29(4):383-4. PubMed ID: 8768591
    [No Abstract]   [Full Text] [Related]  

  • 20. Absence of HTLV-1/2 infection and dermatological diseases in Manaus, State of Amazonas, Brazil.
    Passos LN; Moraes MP; Tamegão-Lopes B; Lemos JA; Machado PR; Mira MT; Talhari S
    Rev Soc Bras Med Trop; 2014 Jul; 47(4):507-9. PubMed ID: 25229293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.